# Antifungal peptides: From modes of action to synergistic and immunologic potential

## TL;DR

Antifungal peptides offer a promising new approach to combat fungal infections, especially as drug resistance rises.

## Contribution

The paper highlights the multimodal therapeutic potential of antifungal peptides, including synergy and immune regulation.

## Key findings

- Antifungal peptides are naturally occurring and can be synthetically engineered for therapeutic use.
- They show promise as next-generation antifungal agents due to their synergistic and immune-regulatory properties.

## Abstract

Fungal infections pose a significant global health threat with rising morbidity and mortality rates. However, the repertoire of effective antifungal drugs remains narrow, a challenge that is further exacerbated by the increasing emergence of (multi)drug-resistant strains. This underscores the urgent need for novel therapeutic strategies. Among them, antifungal peptides (AFPs) have emerged as a promising alternative. AFPs are small, naturally occurring peptides produced by a wide range of organisms, including plants, animals, fungi, and bacteria, as part of their innate immune defense. In addition, synthetic and semisynthetic variants have also been engineered. We here underscore the potential of AFPs as viable candidates for the development of next-generation antifungal therapies. In particular, we advocate their multimodal advantage that spans beyond standalone activity, including their synergistic and immune-regulatory potential.